At a glance
- Originator Aventis
- Class Antimalarials; Antiprotozoals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 18 Oct 1994 No-Development-Reported for Malaria in United Kingdom (Unknown route)
- 18 Oct 1994 No-Development-Reported for Malaria in USA (Unknown route)